Natixis’s NuCana NCNA Stock Holding History

Natixis’s Portfolio NCNA Stock Details NCNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2	Closed	-$45K	–	1146
2020 Q4	$45K	Buy	+2	New	+$48K	﹤0.01%	1025

Other funds holding NCNA

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis's NCNA Position: Q1 2021 in Review

Natixis sold out of NuCana (NCNA) in Q1 2021, closing a stake of 2 shares — an estimated $45K sold.

Natixis first reported a position in NCNA in Q4 2020 and held it in 1 quarter. The position peaked at $45K in Q4 2020. 28 funds tracked by Wall St. Rank hold NCNA as of Q1 2021.

Natixis reported no remaining NuCana position as of Q1 2021 after selling out during the quarter.
Natixis sold 2 NuCana shares in Q1 2021, an estimated $45K.
Natixis first reported a position in NuCana in Q4 2020 and held it in 1 quarter.
Natixis's NuCana position peaked at $45K in Q4 2020.
28 funds tracked by Wall St. Rank held NuCana as of Q1 2021.

Based on Natixis's 13F filing for Q1 2021, filed 14 May 2021.